阿纳莫雷林的处方模式;一种治疗癌症的治疗剂 Cachexia
Yoshihiro Tambo1,2, Shinya Kajiura1,3,2, Akihiro Yoshida2
1The Third Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
Journal of palliative medicine
|July 1, 2024
概括
在化疗期间,癌症缓解症治疗药物阿纳莫雷林 (anamorelin) 经常被处方,特别是在门诊患者的胰腺癌患者. 这表明,在与化疗结合治疗癌症缓解症时,可能会有潜在的益处.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 亚纳莫雷林是日本首个批准用于癌症缓解症的药物,自2021年开始可用.
- 癌症缓解症显著影响患者的生活质量和治疗结果.
- 了解处方模式对于优化治疗用途至关重要.
研究的目的:
- 为了分析anamorelin的处方趋势.
- 为了评估与癌症缓解症患者的阿纳莫雷林使用相关的治疗结果.
- 为了确定患者的特征和临床环境,在哪里anamorelin是最有效的.
主要方法:
- 从2021年7月到2022年12月,在托亚马大学医院进行的回顾性研究.
- 纳入88名癌症缓解症患者,他们被处方了阿纳莫雷林.
- 数据收集包括人口统计,癌症类型,处方设置和饮食摄入量的变化.
主要成果:
- 阿纳莫雷林主要在化疗期间被处方,特别是在门诊患者的胰腺癌患者.
- 大约30%的患者报告增加了饮食摄入量.
- 化疗启动病例的中位治疗持续时间较长 (55天),与仅提供最佳支持性护理 (12天) 相比.
结论:
- 阿纳莫雷林显示出不同的处方模式,有利于在胰腺癌患者中与化疗同时使用.
- 与化疗一起使用可能会增强阿纳莫雷林在治疗癌症缓冲症方面的疗效.
- 量身定制的治疗策略对于最大限度地发挥阿纳莫雷林在癌症缓解症管理中的益处至关重要.
更多相关视频
10:30Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
18.7K
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
